IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Not long at all now
“We are delighted to be coming to market at such an important time for #medicalcannabis across the UK."
General Meeting at 10a.m. on 12th April 2021.
Expected Admission 13th April 2021 and subject to Shareholder and regulatory approval.
A few buys this morning as well. Plenty of news flow to coincide with the RTO and name change, plus further regulatory approvals from the Jamaican Govt.
Should also be further brokers offering online trading by the 13th April. Understand AJ Bell are about to move online with Aquis.
Apollon Formularies
@apollon_uk
·
9h
“We are delighted to be coming to market at such an important time for #medicalcannabis across the UK."
Apollon Formularies
@apollon_uk
·
10m
A capital markets veteran, Mr. Sheil, has joined the Apollon team as a Director. Kevin has worked as a consultant to an AI technology firm, providing valuable input as Apollon grows its line of AI-determined patient specific cannabis medicines #Apollon #MedicalCannabis
A capital markets veteran with over 30 years’ experience, Mr. Sheil has experience across a number of sectors.
Mr Sheil contributes a broad depth of experience and knowledge of capital markets to the board of Apollon. Kevin also brings key expertise to Apollon UK from working as a consultant to an Artificial Intelligence (“AI”) technology firm, providing valuable input as Apollon continues to grow its line of AI-determined patient specific cannabis medicines and commercialise its unique 3D Pharmaceutical Printer.
Mr. Sheil began his career at the London Stock Exchange before moving into corporate broking with HSBC, Credit Lyonnais and Barclays. Mr. Sheil was a telecom sector specialist with Barclays, Credit Suisse and then Citibank where he worked for over 10 years and was consistently top ranked in Extel & Institutional Investor surveys. Mr Sheil worked as Head of Multi-Product Sales at Citibank and was responsible for broking all equity-based products. Mr Sheil has also spent over nine years as a general equity fund manager for Trium Capital Managers.